New Key Statistics Module, Z-Score and F-Score
NAS:ATRA Key Ratios
Market Cap $ M | 82.56 |
Enterprise Value $ M | 91.48 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 8.56 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 8.00 |
EPS (TTM) $ | -2.62 |
Beneish M-Score | -16.93 |
10-y EBITDA Growth Rate % | -5.10 |
5-y EBITDA Growth Rate % | 17.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.34 |
EV-to-EBITDA | -0.34 |
PEG | -- |
Shares Outstanding M | 119.36 |
Net Margin (%) | -3,220.88 |
Operating Margin % | -3,219.48 |
Pre-tax Margin (%) | -3,220.71 |
Quick Ratio | 0.65 |
Current Ratio | 0.72 |
ROA % (ttm) | -107.93 |
ROE % (ttm) | -2,818.48 |
ROIC % (ttm) | -221.26 |
Dividend Yield % | -- |
Altman Z-Score | -22.10 |
Piotroski F-Score | 1.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
ATRA Number of Guru Trades
ATRA Volume of Guru Trades
Gurus Latest Trades with NAS:ATRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ATRA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Atara Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:ATRA
Total 0- 1